Christopher McCormack

2.9k total citations
65 papers, 1.7k citations indexed

About

Christopher McCormack is a scholar working on Dermatology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Christopher McCormack has authored 65 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Dermatology, 29 papers in Pathology and Forensic Medicine and 24 papers in Epidemiology. Recurrent topics in Christopher McCormack's work include Cutaneous lymphoproliferative disorders research (34 papers), Lymphoma Diagnosis and Treatment (21 papers) and Nail Diseases and Treatments (13 papers). Christopher McCormack is often cited by papers focused on Cutaneous lymphoproliferative disorders research (34 papers), Lymphoma Diagnosis and Treatment (21 papers) and Nail Diseases and Treatments (13 papers). Christopher McCormack collaborates with scholars based in Australia, United States and United Kingdom. Christopher McCormack's co-authors include H. Miles Prince, John W. Kelly, A.P. Dorevitch, Stephen Lade, Gail Ryan, Hope Dinh, David Westerman, John F. Seymour, Jonathan Ng and Stephen Hall and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Christopher McCormack

60 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher McCormack Australia 21 1.1k 741 659 545 394 65 1.7k
Adriana García‐Herrera Spain 19 426 0.4× 261 0.4× 614 0.9× 554 1.0× 295 0.7× 84 1.3k
Wing Y. Au China 24 262 0.2× 164 0.2× 1.1k 1.6× 732 1.3× 542 1.4× 75 1.9k
Mireia Camós Spain 22 227 0.2× 133 0.2× 661 1.0× 547 1.0× 329 0.8× 57 1.8k
Gwen Mazoujian United States 20 500 0.5× 298 0.4× 588 0.9× 688 1.3× 149 0.4× 31 2.0k
Nicolas Poulalhon France 17 366 0.3× 317 0.4× 207 0.3× 398 0.7× 129 0.3× 33 1.0k
Mamatha Chivukula United States 23 235 0.2× 192 0.3× 453 0.7× 532 1.0× 132 0.3× 53 1.7k
J. J. Bonerandi France 14 264 0.2× 292 0.4× 89 0.1× 783 1.4× 171 0.4× 25 1.4k
Bernard Lenormand France 20 245 0.2× 154 0.2× 949 1.4× 512 0.9× 336 0.9× 52 1.6k
Jeanette Lundin Sweden 21 352 0.3× 208 0.3× 1.1k 1.7× 544 1.0× 1.1k 2.7× 53 2.2k
Eddie Hu United States 13 273 0.3× 111 0.1× 546 0.8× 383 0.7× 336 0.9× 23 1.1k

Countries citing papers authored by Christopher McCormack

Since Specialization
Citations

This map shows the geographic impact of Christopher McCormack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher McCormack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher McCormack more than expected).

Fields of papers citing papers by Christopher McCormack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher McCormack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher McCormack. The network helps show where Christopher McCormack may publish in the future.

Co-authorship network of co-authors of Christopher McCormack

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher McCormack. A scholar is included among the top collaborators of Christopher McCormack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher McCormack. Christopher McCormack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Prince, H. Miles, Stephen Lade, Michael Fahey, et al.. (2024). 288: Mycosis Fungoides with Large Cell Transformation: Radiotherapy Dose Response and Patient Outcomes. Radiotherapy and Oncology. 194. S1131–S1133. 1 indexed citations
2.
McCormack, Christopher, et al.. (2024). Complete skin remission of Sneddon‐Wilkinson disease with acalabrutinib. Australasian Journal of Dermatology. 66(1). 32–35.
3.
Campbell, Belinda A., Gábor Dobos, Z. Haider, et al.. (2024). Improving disease‐specific survival for patients with Sezary syndrome in the modern era of systemic therapies. British Journal of Haematology. 205(5). 1825–1829. 5 indexed citations
4.
McCormack, Christopher, et al.. (2023). CD30‐positive lymphoproliferative disorders—An Australian Clinical Practice Statement from the Peter MacCallum Cancer Centre. Australasian Journal of Dermatology. 64(2). 194–203. 1 indexed citations
5.
Goh, Michelle, et al.. (2022). Bullous pemphigoid associated with anti‐programmed cell death protein 1 and anti‐programmed cell death ligand 1 therapy: A case series of 13 patients. Australasian Journal of Dermatology. 64(1). 131–137. 6 indexed citations
6.
McCormack, Christopher, et al.. (2021). Patients’ Experiences of Using Skin Self-monitoring Apps With People at Higher Risk of Melanoma: Qualitative Study. JMIR Dermatology. 4(2). e22583–e22583. 2 indexed citations
7.
Weyden, Carrie van der, et al.. (2018). Systemic Treatment Options for Advanced-Stage Mycosis Fungoides and Sézary Syndrome. Current Oncology Reports. 20(4). 32–32. 29 indexed citations
8.
Shanley, Susan & Christopher McCormack. (2016). Diagnosis and Management of Hereditary Basal Cell Skin Cancer. Recent results in cancer research. 205. 191–212. 3 indexed citations
9.
McCormack, Christopher, Rachel Conyers, Richard A. Scolyer, et al.. (2014). Atypical Spitzoid neoplasms. Melanoma Research. 24(5). 437–447. 18 indexed citations
10.
O’Brien, Timothy, Christopher M. Baker, Peter Foley, et al.. (2009). Refractory subacute cutaneous lupus erythematosus successfully treated with rituximab. Australasian Journal of Dermatology. 50(3). 202–206. 20 indexed citations
11.
Prince, H. Miles, et al.. (2008). Extracorporeal photopheresis for the treatment of Sézary syndrome using a novel treatment protocol. Journal of the American Academy of Dermatology. 59(4). 589–595. 30 indexed citations
12.
Dinh, Hope, Christopher McCormack, Stephen Hall, & H. Miles Prince. (2006). Rituximab for the treatment of the skin manifestations of dermatomyositis: A report of 3 cases. Journal of the American Academy of Dermatology. 56(1). 148–153. 72 indexed citations
13.
Sutton, Vivien R., James Biagi, Joseph A. Trapani, et al.. (2005). Lack of apoptosis of Sezary cells in the circulation following oral bexarotene therapy. British Journal of Dermatology. 152(6). 1199–1205. 8 indexed citations
14.
Gibbs, Simon, David Westerman, Christopher McCormack, John F. Seymour, & H. Miles Prince. (2005). Severe and prolonged myeloid haematopoietic toxicity with myelodysplastic features following alemtuzumab therapy in patients with peripheral T‐cell lymphoproliferative disorders. British Journal of Haematology. 130(1). 87–91. 20 indexed citations
15.
Kennedy, Glen, Robert Blum, Christopher McCormack, & H. Miles Prince. (2004). Treatment of primary cutaneous follicular centre lymphoma with rituximab: A report of two cases. Australasian Journal of Dermatology. 45(1). 34–37. 12 indexed citations
16.
Gibbs, Simon, Kirsten Herbert, Christopher McCormack, John F. Seymour, & H. Miles Prince. (2004). Alemtuzumab: effective monotherapy for simultaneous B‐cell chronic lymphocytic leukaemia and Sézary syndrome. European Journal Of Haematology. 73(6). 447–449. 11 indexed citations
17.
Prince, H. Miles, Christopher McCormack, Gail Ryan, et al.. (2003). Management of the primary cutaneous lymphomas. Australasian Journal of Dermatology. 44(4). 227–242. 11 indexed citations
18.
Prince, H. Miles, et al.. (2002). Cutaneous lymphomas: which pathological classification?. Pathology. 34(1). 36–45. 9 indexed citations
19.
Losty, Paul D., et al.. (1990). Type I rupture of the bronchus. Irish Journal of Medical Science (1971 -). 159(3). 80–81. 1 indexed citations
20.
Lanzafame, Raymond J., Christopher McCormack, D. W. O. Rogers, et al.. (1987). Mechanisms of carbon dioxide laser reduction of tumor recurrence in experimental mammary tumor. Lasers in Surgery and Medicine. 7(1). 87. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adriana García‐Herrera Breakdown of academic impact, for papers by Wing Y. Au Breakdown of academic impact, for papers by Mireia Camós Breakdown of academic impact, for papers by Gwen Mazoujian Breakdown of academic impact, for papers by Nicolas Poulalhon Breakdown of academic impact, for papers by Mamatha Chivukula Breakdown of academic impact, for papers by J. J. Bonerandi Breakdown of academic impact, for papers by Bernard Lenormand Breakdown of academic impact, for papers by Jeanette Lundin Breakdown of academic impact, for papers by Eddie Hu
Rankless by CCL
2026